Comparing recall rates, cancer detection in breast cancer screenings
(JAMA Network) Nearly 200 radiologists who interpreted about 251,000 digital breast tomosynthesis (DBT) and 2 million digital mammography screening examinations were included in this observational study that evaluated recall and cancer detection rates.
Publication date: Available online 9 October 2020Source: Materials Today: ProceedingsAuthor(s): G. Meenalochini, S. Ramkumar
ConclusionsThis study contains the largest population dataset of ILC evaluated to date. While total breast cancer incidence rates in Ontario are largely unchanged, ILC incidence rates are steadily increasing and there is a trend towards diagnosis of ILC at a later stage. These trends highlight the ongoing diagnostic and treatment challenge ILC presents for patients and clinicians.
Conclusions: This study will provide reliable evidence for intervention for reducing anxiety in women receiving screening mammography. INPLASY registration number: INPLASY202070131.
This study aimed to evaluate the awareness and practice of breast self-examination (BSE) and the awareness of screening and risk factors for breast cancer among patients from a mastology clinic and to associate such findings with sociodemographic factors of that population. A total of 202 randomly selected patients from the outpatient clinic of the Mastology Unit of S ão Paulo School of Medicine were interviewed. A structured questionnaire was used and included questions regarding sociodemographic variables, questions to assess the knowledge and practice of BSE, and knowledge of mammographic screening and risk facto...
Condition: Breast Cancer Intervention: Combination Product: Contrast Enhanced Mammography Sponsors: Karolinska Institutet; Stockholm South General Hospital Not yet recruiting
Not all benign findings on screening mammography are equal. A Spanish team...Read more on AuntMinnie.comRelated Reading: CT scans can predict CVD risk in breast cancer patients Language can be barrier to breast screening Breast screening helps precision medicine succeed Notification laws may not lead to more breast screening Language matters when screening women with dense breasts
CONCLUSIONS: This unique tailored approach to risk assessment will further empower females and clinicians towards a more informed clinical decision process regarding future imaging pathways. It will also inform health policy decisions regarding alternate screening durations and intervals. ADVANCES IN KNOWLEDGE: Breast-iRRISC is a novel tool that provides females, clinicians and health policymakers around the globe with the ability to quantify the lifetime risk of radiation-induced breast cancer from screening mammography on an individual level from a single exposure. PMID: 33031706 [PubMed - as supplied by publisher]
Clinicians used CT scans of coronary artery calcium to predict which patients...Read more on AuntMinnie.comRelated Reading: Radiation tied to breast cancer delays for Black women Women with DCIS have 3x the risk of breast cancer death Single radiotherapy dose effective for breast cancer Radiologists, AI make a great team in screening mammo AI software can cut screening mammography workload
The U.S. National Comprehensive Cancer Network (NCCN) is updating translations...Read more on AuntMinnie.comRelated Reading: ASBrS releases risk-based breast screening guidelines ACP pushes breast cancer screening start from 40 to 50 CancerIQ collaborates with NCCN ACR adds resources to Mammography Saves Lives site Should Pink October really be Pink February?
One in three women delayed their mammograms due to COVID-19, and 45% are nervous...Read more on AuntMinnie.comRelated Reading: Notification laws may not lead to more breast screening AMVC Fall 2020: AI can reshape radiology post-COVID-19 Radiation tied to breast cancer delays for Black women Do breast screening guidelines overlook Black women? Mobile mammo leads to early detection for vulnerable women